INTERIM REPORT
JANUARY 1 - JUNE 30, 2026
Positive development across AddLife’s companies
AddLife’s companies are performing well across the board, with stronger margins, good growth and increased cash flow. Our improvement efforts are yielding clear results, and our recently acquired companies are making a significant contribution to earnings growth. At the same time, we are actively pursuing further acquisitions.
Fredrik Dalborg, President and CEO
- Net sales by percent to SEK million (). Adjusted for operations divested in December 2025, organic growth amounted to 4 percent and acquired growth amounted to percent.
- EBITA by percent to SEK million (), corresponding to an EBITA margin of percent ().
- Profit after tax by percent to SEK million ().
- Earnings per share amounted to SEK ().
- Cash flow from operating activities amounted to SEK million ().
- During the quarter, the acquisition of CoaChrom Diagnostica GmbH, Austria, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 110 million.
- Net sales by percent to SEK million (). Adjusted for operations divested in December 2025, organic growth amounted to 3 percent, acquired growth amounted to 2 percent, and exchange rate effects had a impact of percent.
- EBITA by percent to SEK million (), corresponding to an EBITA margin of percent (). Exchange rate effects had a impact of percent on EBITA.
- Profit after tax by percent to SEK million ().
- Earnings per share amounted to SEK (). For the latest 12‑month period, earnings per share amounted to ().
- Cash flow from operating activities amounted to SEK million ().
- The equity ratio was percent ().
- Return on working capital (P/WC) amounted to percent ().
- During the interim period, two acquisitions were completed. The acquisitions are expected to contribute annual net sales of approximately SEK 185 million.
| Q2 | Q2 | ∆ | Jan-Jun | Jan-Jun | ∆ | Jul 2025- | Full year | |
| SEKm | 2026 | 2025 | % | 2026 | 2025 | % | Jun 2026 | 2025 |
| Net sales | 2,721 | 2,578 | 6 | 5,366 | 5,280 | 2 | 10,528 | 10,442 |
| EBITA | 342 | 307 | 11 | 674 | 650 | 4 | 1,441 | 1,417 |
| EBITA margin, % | 12.6 | 11.9 | 12.6 | 12.3 | 13.7 | 13.6 | ||
| Adjusted EBITA | 342 | 307 | 11 | 674 | 650 | 4 | 1,283 | 1,259 |
| Adjusted EBITA margin, % | 12.6 | 11.9 | 12.6 | 12.3 | 12.2 | 12.1 | ||
| Profit/loss before taxes | 189 | 146 | 29 | 372 | 318 | 17 | 826 | 772 |
| Profit for the period | 130 | 100 | 30 | 258 | 220 | 17 | 600 | 562 |
| Earnings per share (EPS), before/after dilution, SEK | 1.06 | 0.83 | 28 | 2.11 | 1.81 | 17 | 4.89 | 4.59 |
| Cash flow from operating activities | 165 | 119 | 38 | 269 | 359 | -25 | 1,302 | 1,392 |
4%
ORGANIC GROWTH
11%
EBITA GROWTH
%
EBITA MARGIN
%
P/WC
